| Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial M Valgimigli, A Gagnor, P Calabro, E Frigoli, S Leonardi, T Zaro, ... Lancet 385, 2465-2476, 2015 | 1506 | 2015 |
| Dual antiplatelet therapy after PCI in patients at high bleeding risk M Valgimigli, E Frigoli, D Heg, J Tijssen, P Jüni, P Vranckx, Y Ozaki, ... New England Journal of Medicine 385 (18), 1643-1655, 2021 | 443 | 2021 |
| Bivalirudin or unfractionated heparin in acute coronary syndromes M Valgimigli, E Frigoli, S Leonardi, M Rothenbühler, A Gagnor, P Calabrò, ... New England Journal of Medicine 373 (11), 997-1009, 2015 | 424 | 2015 |
| Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a … M Valgimigli, E Frigoli, S Leonardi, P Vranckx, M Rothenbühler, M Tebaldi, ... The Lancet 392 (10150), 835-848, 2018 | 301 | 2018 |
| Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management: AKI-MATRIX G Andò, B Cortese, F Russo, M Rothenbühler, E Frigoli, G Gargiulo, ... Journal of the American College of Cardiology 69 (21), 2592-2603, 2017 | 161 | 2017 |
| Incremental value of the CRUSADE, ACUITY, and HAS‐BLED risk scores for the prediction of hemorrhagic events after coronary stent implantation in patients undergoing long or … F Costa, JG Tijssen, S Ariotti, S Giatti, E Moscarella, P Guastaroba, ... Journal of the American Heart Association 4 (12), e002524, 2015 | 113 | 2015 |
| Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6-or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre … F Costa, P Vranckx, S Leonardi, E Moscarella, G Andò, P Calabro, ... European heart journal 36 (20), 1242-1251, 2015 | 112 | 2015 |
| Radial access reduces mortality in patients with acute coronary syndromes: results from an updated trial sequential analysis of randomized trials G Andò, D Capodanno JACC: Cardiovascular Interventions 9 (7), 660-670, 2016 | 110 | 2016 |
| Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome. A Systematic Review and Meta-analysis G Andò, D Capodanno Annals of internal medicine 163 (12), 932-940, 2015 | 107 | 2015 |
| Prognostic implications of declining hemoglobin content in patients hospitalized with acute coronary syndromes S Leonardi, F Gragnano, G Carrara, G Gargiulo, E Frigoli, P Vranckx, ... Journal of the American College of Cardiology 77 (4), 375-388, 2021 | 100 | 2021 |
| Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: a systematic review and network meta-analysis G Andò, P Capranzano International journal of cardiology 231, 162-169, 2017 | 100 | 2017 |
| Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome G Tarantini, M Mojoli, F Varbella, R Caporale, S Rigattieri, G Ando, ... Journal of the American College of Cardiology 76 (21), 2450-2459, 2020 | 97 | 2020 |
| Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast‐induced nephropathy in patients with acute myocardial infarction undergoing primary … G Andò, G Morabito, C de Gregorio, O Trio, F Saporito, G Oreto Catheterization and Cardiovascular Interventions 82 (6), 878-885, 2013 | 97 | 2013 |
| Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology U Zeymer, P Ludman, N Danchin, P Kala, C Laroche, M Sadeghi, ... European heart journal 42 (44), 4536-4549, 2021 | 80 | 2021 |
| Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial S Leonardi, E Frigoli, M Rothenbühler, E Navarese, P Calabró, P Bellotti, ... bmj 354, 2016 | 72 | 2016 |
| Abbreviated antiplatelet therapy in patients at high bleeding risk with or without oral anticoagulant therapy after coronary stenting: an open-label, randomized, controlled trial PC Smits, E Frigoli, J Tijssen, P Jüni, P Vranckx, Y Ozaki, MC Morice, ... Circulation 144 (15), 1196-1211, 2021 | 71 | 2021 |
| Renal function–adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary … G Andò, C de Gregorio, G Morabito, O Trio, F Saporito, G Oreto Circulation: Cardiovascular Interventions 7 (4), 465-472, 2014 | 70 | 2014 |
| Pharmacokinetics of new oral anticoagulants: implications for use in routine care Y Ingrasciotta, S Crisafulli, V Pizzimenti, I Marciano, A Mancuso, G Ando, ... Expert Opinion on Drug Metabolism & Toxicology 14 (10), 1057-1069, 2018 | 67 | 2018 |
| Scientific foundation and possible implications for practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of AngioX … M Valgimigli, P Calabrò, B Cortese, E Frigoli, S Garducci, P Rubartelli, ... Journal of cardiovascular translational research 7, 101-111, 2014 | 67* | 2014 |
| Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease F Tomai, F Ribichini, AS Ghini, V Ferrero, G Ando, C Vassanelli, F Romeo, ... European heart journal 26 (20), 2099-2105, 2005 | 66 | 2005 |
Marco ValgimigliCardiocentro TicinoVerifisert e-postadresse på unife.it
